However, protein synthesis is unperturbed by targeting the AR-CaMKK2-AMPK pathway in prostate cancer cells, suggesting that although CaMKK2 stimulates glycolysis, it has no significant effects on biosynthesis [42]. The gene discussed is PRKAA1; the disease is prostate cancer.